Nicolás Ortonne

8.7k total citations
203 papers, 4.8k citations indexed

About

Nicolás Ortonne is a scholar working on Dermatology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Nicolás Ortonne has authored 203 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Dermatology, 85 papers in Pathology and Forensic Medicine and 59 papers in Epidemiology. Recurrent topics in Nicolás Ortonne's work include Cutaneous lymphoproliferative disorders research (62 papers), Lymphoma Diagnosis and Treatment (41 papers) and Autoimmune Bullous Skin Diseases (34 papers). Nicolás Ortonne is often cited by papers focused on Cutaneous lymphoproliferative disorders research (62 papers), Lymphoma Diagnosis and Treatment (41 papers) and Autoimmune Bullous Skin Diseases (34 papers). Nicolás Ortonne collaborates with scholars based in France, United States and Germany. Nicolás Ortonne's co-authors include P. Wolkenstein, L. Valeyrie‐Allanore, M. Bagot, S. Oro, O. Chosidow, Andreas Schedl, Valérie Vidal, Martine Bagot, Armand Bensussan and Laurent Lantieri and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Nicolás Ortonne

187 papers receiving 4.7k citations

Peers

Countries citing papers authored by Nicolás Ortonne

Since Specialization

Citations

This map shows the geographic impact of Nicolás Ortonne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolás Ortonne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolás Ortonne more than expected).

Fields of papers citing papers by Nicolás Ortonne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolás Ortonne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolás Ortonne. The network helps show where Nicolás Ortonne may publish in the future.

Co-authorship network of co-authors of Nicolás Ortonne

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolás Ortonne. A scholar is included among the top collaborators of Nicolás Ortonne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolás Ortonne. Nicolás Ortonne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Glial-to-mesenchymal transition of tumor Schwann cells drives the genetic burden in MPNSTs from neurofibromatosis type 1 mouse model 2025 ·Science Advances ·Katarzyna J. Radomska, (unknown), Laure Lecerf, Bastien Job, (unknown), (unknown), (unknown), Denis Thieffry, Patrick Charnay, P. Wolkenstein, Nicolás Ortonne, (unknown), Piotr Topilko	0
2	Erythema multiforme 2024 ·EClinicalMedicine ·Elio Kechichian, N. Dupin, David A. Wetter, Nicolás Ortonne, (unknown), O. Chosidow	2
3	Whole-Body Positron Emission Tomography with 18F-Fluorodeoxyglucose/Magnetic Resonance Imaging as a Screening Tool for the Detection of Malignant Transformation in Individuals with Neurofibromatosis Type 1 2024 ·Journal of Investigative Dermatology ·L. Fertitta, (unknown), O. Zehou, Christina Bergqvist, S. Ferkal, (unknown), Lionel Lerman, Sebastien Mulé, Alain Luciani, Blanche Bapst, Khaled Ezzedine, Nicolás Ortonne, Emmanuel Itti, P. Wolkenstein	3
4	KILT: A RANDOMIZED NON‐COMPARATIVE PHASE II LYSA STUDY OF LACUTAMAB WITH GEMOX VERSUS GEMOX IN RELAPSED/REFRACTORY PERIPHERAL T‐CELL LYMPHOMA 2023 ·Hematological Oncology ·Morgane Cheminant, Sylvain Carras, Julie Bruneau, François Lemonnier, Emmanuel Bachy, Charles Herbaux, Pierre Feugier, Nicolas Daguindau, Thomas Gastinne, (unknown), (unknown), Borhane Slama, (unknown), Franck Morschhauser, Olivier Tournilhac, Philippe Gaulard, Vahid Asnafi, Nicolás Ortonne, Gandhi Damaj, Olivier Hermine	0
5	Harmonization of programmed death‐ligand 1 immunohistochemistry and mRNA expression scoring in metastatic melanoma: a multicentre analysis 2022 ·Histopathology ·(unknown), Julien Adam, Laurence Lamant, Maxime Battistella, Nicolás Ortonne, B. Balme, Arnaud de la Fouchardière, Léonor Chaltiel, E. Gérard, Camille Franchet, B. Vergier	6
6	Idylla MSI test as a new tool for microsatellite instability detection in sebaceous tumours and keratoacanthomas 2021 ·Journal of Clinical Pathology ·(unknown), (unknown), (unknown), Nicolás Ortonne, Anaïs Pujals	6
7	ICOS is widely expressed in cutaneous T-cell lymphoma and its targeting promotes potent killing of malignant cells 2021 ·European Journal of Cancer ·F. Amatore, Nicolás Ortonne, Marc Lopez, Florence Orlanducci, Rémy Castellano, S. Oro, (unknown), Laurent Gorvel, Armelle Goubard, Réda Bouabdallah, Jean‐Marc Schiano de Colella, Nathalie Bonnet, Jean‐Jacques Grob, Philippe Gaulard, M. Bagot, Armand Bensussan, Éric Delaporte, Daniel Olive	1
8	Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders 2020 ·The American Journal of Surgical Pathology ·(unknown), Nicolás Ortonne, Laura Pelletier, M. Beylot‐Barry, S. Oro, F. Franck, (unknown), Catherine Godfraind, Marie-Hélène Delfau, M. D’Incan, B. Vergier	28
9	TLR-9 agonist and CD40-targeting vaccination induces HIV-1 envelope-specific B cells with a diversified immunoglobulin repertoire in humanized mice 2020 ·PLoS Pathogens ·Véronique Godot, Colas Tchérakian, Laurine Gil, Iñaki Cervera-Marzal, Guangming Li, Liang Cheng, Nicolás Ortonne, Jean‐Daniel Lelièvre, Giuseppe Pantaleo, Craig Fenwick, Mireille Centlivre, Hugo Mouquet, Sylvain Cardinaud, Sandra Zurawski, Gérard Zurawski, Pierre Milpied, Lishan Su, Yves Lévy	18
10	Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adults 2016 ·British Journal of Dermatology ·J. Gottlieb, S. Oro, M. Alexandre, S. Grootenboer‐Mignot, Françoise Aucouturier, É. Sbidian, Emmanuelle Tancrède‐Bohin, Pierre Schneider, (unknown), C. Picard‐Dahan, É. Bégon, C. Pauwels, K. Cury, Sophie Hüe, (unknown), Nicolás Ortonne, F. Caux, P. Wolkenstein, O. Chosidow, C. Prost‐Squarcioni	34
11	Facial Scars following Toxic Epidermal Necrolysis: Role of Adnexal Involvement? 2016 ·Dermatology ·(unknown), Nicolás Ortonne, A. Colin, Jean‐Paul Meningaud, O. Chosidow, P. Wolkenstein, L. Valeyrie‐Allanore	5
12	Cutaneous Invasive Aspergillosis 2015 ·Medicine ·(unknown), F. Foulet, S. Oro, Nicolás Ortonne, Karine Sitbon, G. Quéreux, Olivier Lortholary, O. Chosidow, Stéphane Bretagne	51
13	Blastic Plasmacytoid Dendritic Cell Neoplasms 2014 ·The American Journal of Surgical Pathology ·(unknown), Stéphane Dalle, Gérard Duru, B. Balme, B. Vergier, Nicolás Ortonne, Marie‐Dominique Vignon‐Pennamen, Valérie Costes‐Martineau, Laurence Lamant, S. Dalac, Claire Delattre, Pierre Déchelotte, Philippe Courville, A. Carlotti, A. De Muret, Sylvie Fraitag, Annie Lévy, Andrew Mitchell, Tony Petrella	80
14	Syringomatous carcinoma: case report of a rare tumor entity 2012 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Issam Lalya, Mohamed Oukabli, (unknown), Nicolás Ortonne	2
15	Specific Skin Lesions in Chronic Myelomonocytic Leukemia 2012 ·The American Journal of Surgical Pathology ·(unknown), Bettina Fabiani, Claire Bénet, S. Dalac, B. Balme, Claire Delattre, B. Vergier, M. Beylot‐Barry, (unknown), Nicolás Ortonne, (unknown), A. Carlotti, (unknown), É. Frouin, (unknown), L. Laroche, Ivan Théate, Franck Monnien, Francine Mugneret, Tony Petrella	73
16	Feasibility, Reproducibility, Risks and Benefits of Face Transplantation: A Prospective Study of Outcomes 2011 ·American Journal of Transplantation ·Laurent Lantieri, Mikaël Hivelin, Vincent Audard, M. Benjoar, Jean‐Paul Meningaud, Frank Bellivier, Nicolás Ortonne, (unknown), A Gilton, Caroline Suberbielle, J.-P. Marty, Philippe Lang, Philippe Grimbert	152
17	Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions 2011 ·Journal of the European Academy of Dermatology and Venereology ·J. J. Bonerandi, Céline Beauvillain, (unknown), (unknown), V. Chaussade, P. Clavère, C. Desouches, Federico Garnier, J.‐L. Grolleau, M Grossin, Anne Jourdain, (unknown), H. Maillard, Nicolás Ortonne, E. Rio, (unknown), J.‐F. Séi, Jean‐Jacques Grob, Ludovic Martin	117
18	Endocardites infectieuses en service de dermatologie 2009 ·Annales de Dermatologie et de Vénéréologie ·(unknown), L. Valeyrie‐Allanore, (unknown), (unknown), Nicolás Ortonne, J.C. Roujeau, Martine Bagot	2
19	Microarray-Based Identification of Tenascin C and Tenascin XB , Genes Possibly Involved in Tumorigenesis Associated with Neurofibromatosis Type 1 2007 ·Clinical Cancer Research ·Pascale Lévy, Hugues Ripoche, Ingrid Laurendeau, Vladimir Lazar, Nicolás Ortonne, Béatrice Parfait, Karen Leroy, Janine Wechsler, Isabelle Salmon, P. Wolkenstein, Philippe Dessen, Michel Vidaud, Dominique Vidaud, Ivan Bièche	43
20	Identification of a Novel CD160+CD4+ T-Lymphocyte Subset in the Skin: A Possible Role for CD160 in Skin Inflammation 2007 ·Journal of Investigative Dermatology ·(unknown), Jérôme Giustiniani, Nicolás Meyer, Valérie Schiavon, Nicolás Ortonne, José A. Campillo, Martine Bagot, Armand Bensussan	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact